TMDX

61.70

1.93% 1.17

Dopo l'orario di chiusura: 62.00 0.30 +0.49%

Transmedics Group Inc (TMDX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TMDX Giù? Forum Previsione

Precedente Chiudi:

$60.53

Aprire:

$60

Volume 24 ore:

1.52M

Relative Volume:

0.85

Capitalizzazione di mercato:

$2.07B

Reddito:

$401.09M

Utile/perdita netta:

$32.64M

Rapporto P/E:

-56.09

EPS:

-1.1

Flusso di cassa netto:

$-120.51M

1 W Prestazione:

-3.98%

1M Prestazione:

-20.08%

6M Prestazione:

-57.15%

1 anno Prestazione:

-20.11%

Intervallo 1D:

$59.72

$62.50

Intervallo di 1 settimana:

$59.72

$66.44

Portata 52W:

$59.72

$177.37

Transmedics Group Inc Stock (TMDX) Company Profile

Nome

Transmedics Group Inc

Settore

Healthcare (1176)

Industria

Medical Devices (148)

Telefono

(978) 552-0900

Indirizzo

200 MINUTEMAN ROAD, ANDOVER, MA

Dipendente

584

Cinguettio

@transmedics

Prossima data di guadagno

2024-10-28

Ultimi documenti SEC

TMDX's Discussions on Twitter

Confronta TMDX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TMDX Transmedics Group Inc	61.70	2.07B	401.09M	32.64M	-120.51M	0.94
ABT Abbott Laboratories	114.23	198.13B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	364.60	138.99B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	88.95	131.10B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	81.03	103.90B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	74.81	44.12B	6.60B	4.16B	490.10M	6.93

Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-17	Downgrade	JP Morgan	Overweight → Neutral
2024-11-22	Downgrade	Needham	Buy → Hold
2024-10-29	Reiterato	Needham	Buy
2024-10-29	Reiterato	Oppenheimer	Outperform
2024-09-24	Iniziato	Robert W. Baird	Outperform
2024-08-21	Iniziato	Needham	Buy
2024-06-06	Iniziato	Cantor Fitzgerald	Overweight
2024-06-04	Iniziato	Stephens	Overweight
2024-03-28	Iniziato	Piper Sandler	Overweight
2023-07-19	Iniziato	Robert W. Baird	Outperform
2022-08-02	Aggiornamento	JP Morgan	Neutral → Overweight
2020-10-08	Downgrade	JP Morgan	Overweight → Neutral
2020-04-07	Iniziato	Oppenheimer	Outperform
2019-05-28	Iniziato	Canaccord Genuity	Buy
2019-05-28	Iniziato	Cowen	Outperform
2019-05-28	Iniziato	JP Morgan	Overweight
2019-05-28	Iniziato	Morgan Stanley	Equal-Weight

Mostra tutto

Transmedics Group Inc Borsa (TMDX) Ultime notizie

Dec 19, 2024

TransMedics Group (NASDAQ:TMDX) Reaches New 1-Year LowHere's Why - MarketBeat

Dec 19, 2024

Dec 18, 2024

TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.4%Here's Why - MarketBeat

Dec 18, 2024

Geode Capital Management LLC Has $119.94 Million Holdings in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat

Dec 18, 2024

Dec 17, 2024

TransMedics Group (NASDAQ:TMDX) Receives "Neutral" Rating from JPMorgan Chase & Co. - MarketBeat

Dec 17, 2024

Dec 16, 2024

TransMedics Stock Plunges 57.5% in Three Months: What's Next? - MSN

Dec 16, 2024

TransMedics Group's SWOT analysis: organ transplant tech stock faces growth hurdles - Investing.com Canada

Dec 16, 2024

TransMedics Group's SWOT analysis: organ transplant tech stock faces growth hurdles By Investing.com - Investing.com South Africa

Dec 16, 2024

Dec 14, 2024

TMDX stock touches 52-week low at $64.83 amid market shifts By Investing.com - Investing.com South Africa

Dec 14, 2024

Dec 13, 2024

TMDX stock touches 52-week low at $64.83 amid market shifts - Investing.com

Dec 13, 2024

TransMedics reports inducement grants under Nasdaq listing rule - Medical Buyer

Dec 13, 2024

Research Analysts Set Expectations for TMDX Q3 Earnings - MarketBeat

Dec 13, 2024

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Kilgore News Herald

Dec 13, 2024

Dec 12, 2024

TransMedics Welcomes New CFO with $1.4M Equity Package; Grants Strategic Inducement Awards - StockTitan

Dec 12, 2024

Q1 EPS Estimate for TransMedics Group Decreased by Analyst - MarketBeat

Dec 12, 2024